ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1005

Histone Lysine Demethylase KDM6A Mediates Joint Destruction in Osteoarthritic Knees By Epigenetic Disturbance of SOX9 Promoter and Histone H3K27

Feng-Sheng Wang1, Pe-Chin Chuang1, Yi-Chih Sun1, Yu-Shan Chen1 and Jih-Yang Ko2, 1Department of Medical Research, Kaohsiung Chang Gung Memorial Hospital, Taiwan, Kaohsiung, Taiwan, 2Department of Orthopedic Surgery, Kaohsiung Chang Gung Memorial Hospital, Taiwan, Kaohsiung, Taiwan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: cartilage, Histone Modification, joint damage, osteoarthritis and synovium

  • Tweet
  • Email
  • Print
Session Information

Session Title: Biology and Pathology of Bone and Joint: Cartilage, Synovium and Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Intensive articular cartilage deterioration and synovial fibrosis in joints are prominently pathogenic features of osteoarthritic (OA) knees. Epigenetic reactions in joint microenvironments are linked to the incidence of OA knees. Histone lysine demethylase KDM6A is an emerging epigenetic regulator cntributing to tissue development and remodeling. This study was undertaken to investigate the biological roles of KDM6A in joint integrity of OA knees and decipher the epigenetic actions of KDM6A on methylation statuses of master cartilage regulator SOX9 promoter and histone 3 lysine 27 (H3K27) and metabolism of cartilage and synovial matrices in OA knee joints.   

Methods:   Mice with collagenase-induced OA knees were weekly administered with KDM6A inhibitor GSK-J4 or vehicle for 12 weeks. Gait profiles, fluorescence probe 2-deoxyglucose uptake by inflammatory tissues, and subchondral bone microstructures were analyzed using Catwalk, near infrared fluorescence in vivo imaging and μCT. Quantitative RT-PCR, immunoblotting, methylation-specific PCR, and chromatin immunoprecipitation were performed to quantify mRNA, protein expression, methylation statuses and enrichments of SOX9 promoter and H3K27. 

Results:   Articular cartilage damage and synovial fibrosis were in conjunction with increased expression of KDM6A, KDM6B and decreased levels of SOX9 and methylated H3K27 in OA knee joints. Administration with KDM6A inhibitor GSK-J4 alleviated the deleterious effects of OA on gait characteristics (maximum contact intensity, area and print area of paws) and joint inflammation. It also improved subchondral bone microarchitecture (trabecular volume, thickness, number and cortical porosity) and bone mineral density of affected joints. Inhibition of KDM6A attenuated the adverse effects of OA on chondrogenic matrix expression, morphology and OARSI scores of articular cartilage, as well as mitigated nucleated cell infiltration, hypervascularization and fibrotic matrix accumulation in synovial compartments. Loss of KDM6A signaling restored methylation of CpG islands in SOX9 promoter and alleviated the OA-mediated inhibition of SOX9 mRNA transcription and protein levels. Treatment with KDM6A inhibitor also increased H3K27 methylation that reduced the enrichment of H3K27 to proximal promoter region of fibrogenic transcription factor AP-1 and profibrotic gene expression in injured joint tissues.

Conclusion:   KDM6A induces SOX9 promoter and H3K27 hypomethylation that deregulates SOX9 and AP-1 actions on articular cartilage integrity and synovium homeostasis in the pathogenesis of OA knees. Inhibition of KDM6A ameliorates the OA-mediated epigenetic dysfucntion in cartilage and synovium, thereby protects aganist excessive joint remodeling. This study sheds emerging lights on epigenetic modulation of joint integrity in OA knees and highlights that pharmaceutical modulation of KDM6A actions has therapeutic potentials for preventing against OA-induced joint damage.


Disclosure:

F. S. Wang,
None;

P. C. Chuang,
None;

Y. C. Sun,
None;

Y. S. Chen,
None;

J. Y. Ko,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/histone-lysine-demethylase-kdm6a-mediates-joint-destruction-in-osteoarthritic-knees-by-epigenetic-disturbance-of-sox9-promoter-and-histone-h3k27/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.